Patent details

Basic Information

Publication number:

EP1673473

PCT Application Number:

PCT/EP/2004/011124

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047658315

PCT Publication Number:

WO/2005/040416

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF GENETIC POLYMORPHISMS THAT ASSOCIATE WITH EFFICACY OF TREATMENT OF INFLAMMATORY DISEASE

French Title of Invention:

UTILISATION DE POLYMORPHISMES GENETIQUES COMPATIBLES AVEC L'EFFICACITE DE TRAITEMENT DES MALADIES INFLAMMATOIRES

German Title of Invention:

VERWENDUNG VON MIT DER WIRKSAMKEIT DER BEHANDLUNG EINER ENTZÜNDUNGSKRANKHEIT ASSOZIIERTEN GENETISCHEN POLYMORPHISMEN

SPC Number:

Dates

Filing date:

05/10/2004

Grant date:

06/07/2011

EP Publication Date:

06/07/2011

PCT Publication Date:

06/05/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/06/2006

EP B1 Publication Date:

06/07/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/10/2011

Expiration date:

05/10/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/10/2004

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

LAVEDAN Christian, Nicolas

Address:

United States (US)

2

Name:

IDE Susan

Address:

United States (US)

3

Name:

McCULLOUGH Karen

Address:

United States (US)

Priority

Priority Number:

508971 P

Priority Date:

06/10/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

C12Q 1/68;

Filing date	Document type	Number of pages